Ortin Global Limited Share Price & Technical Analysis
ORTINGLOBE · ₹15.70 (+2.41%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹15.70
+2.41%
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quino…
Price chart
Seasonality
May has 1 positive and 1 negative years (last 3 years shown)
1% return in May, -1% avg return in past 3 year May month.
12% return in 2026, -16% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | 32% | -21% | 9% | 1% | – | – | – | – | – | – | – | 12% |
| 25 | -9% | -30% | -18% | 10% | -1% | 14% | 24% | -14% | -13% | -2% | 10% | 16% | -13% |
| 24 | – | – | – | – | – | – | – | 4% | -1% | -9% | -2% | -11% | -19% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Uptrend · Uptrend
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; research and development services for new formulation brands; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; operates as a merchant exporter of pharmaceutical finished formulations; and engages in real estate. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹119.45M
P/E ratio
—
52W high
₹19.90
52W low
₹10.32
Volume
11,483
Beta
0.52
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Ortin Global Limited share price today?
- Ortin Global Limited (ORTINGLOBE) last traded around ₹15.70 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ORTINGLOBE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ORTINGLOBE. Download the app for real-time alerts.
- How can I analyze Ortin Global Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.